Canopy Growth (CGC) Gains from Investment Securities (2019 - 2025)
Canopy Growth's (CGC) quarterly Gains from Investment Securities came in at -$4.6 million in Q4 2025, down 215.38% quarter-over-quarter from -$1.5 million in Q1 2025.
Canopy Growth (CGC) Gains from Investment Securities (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Gains from Investment Securities across 7 years of filings, most recently posting -$4.6 million for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$4.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.5 million (up 4.26% YoY), and the FY2025 annual result was -$1.5 million, down 170.13% from the prior year.
- Gains from Investment Securities came in at -$4.6 million for Q4 2025 at Canopy Growth, down from -$1.5 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $26.4 million in Q1 2021 to a low of -$43.6 million in Q1 2022.
- The 5-year median for Gains from Investment Securities is $1.3 million (2021), against an average of -$56852.1.
- Peak annual rise in Gains from Investment Securities reached 1855.21% in 2024, while the deepest fall reached 285.35% in 2024.
- Canopy Growth's Gains from Investment Securities stood at $4.7 million in 2021, then decreased by 19.86% to $3.8 million in 2022, then plunged by 100.86% to -$32075.0 in 2023, then surged by 1855.21% to $562985.0 in 2024, then plunged by 915.18% to -$4.6 million in 2025.
- The last three Gains from Investment Securities figures came in at -$4.6 million (Q4 2025), -$1.5 million (Q1 2025), and $562985.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Canopy Growth | 11.27 Mn | -137.42 Mn | 15.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.59 Mn |
| Dec 31, 2025 | -4.59 Mn |
| Mar 31, 2025 | -1.46 Mn |
| Mar 31, 2025 | -1.46 Mn |
| Sep 30, 2024 | 562,985.02 |
| Sep 30, 2024 | 562,985.02 |
| Jun 30, 2024 | -561,515.94 |
| Jun 30, 2024 | -561,515.94 |
| Mar 31, 2024 | -5.73 Mn |
| Mar 31, 2024 | -5.73 Mn |
| Sep 30, 2023 | -32,075.01 |
| Sep 30, 2023 | -32,075.01 |
| Jun 30, 2023 | 7.86 Mn |
| Jun 30, 2023 | 7.86 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Mar 31, 2022 | -43.58 Mn |
| Mar 31, 2022 | -43.58 Mn |